Precipio (PRPO) P/E (2011 - 2026)
Precipio (PRPO) P/E from Mar 31, 2011 to Jun 3, 2026. The TTM Precipio (PRPO) P/E is -47.20. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Precipio (PRPO)
| Year | P/E | Change |
|---|---|---|
| 2026 | -47.20 | -41.05% |
| 2025 | -80.06 | +4163.97% |
| 2024 | -1.88 | +110.98% |
| 2023 | -0.89 | -14.18% |
| 2022 | -1.04 | -74.35% |
| 2021 | -4.04 | +54.83% |
| 2020 | -2.61 | +169.26% |
| 2019 | -0.97 | +278.97% |
| 2018 | -0.26 | -86.38% |
| 2017 | -1.88 | +948.86% |
| 2016 | -0.18 | -62.74% |
| 2015 | -0.48 | -96.88% |
| 2014 | -15.42 | +336.96% |
| 2013 | -3.53 | -24.59% |
| 2012 | -4.68 | -26.11% |
| 2011 | -6.33 | N/A |
Comparison Precipio (PRPO) P/E with competitors
Precipio (PRPO) P/E is -47.20.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 0.78 | -101.65% |
| MBAI | CheckCap Ltd | 2.88 | -106.11% |
| FONR | Fonar Corp | 15.41 | -132.66% |
| QGEN | Qiagen NV | 17.55 | -137.18% |
| IQV | IQVIA Holdings Inc | 20.25 | -142.91% |
| DGX | Quest Diagnostics Inc | 21.62 | -145.81% |
| LH | Laboratory Corp Of America Holdings | 22.66 | -148.02% |
| A | Agilent Technologies Inc | 25.45 | -153.92% |
| MEDP | Medpace Holdings Inc | 26.32 | -155.78% |
| TMO | Thermo Fisher Scientific Inc | 26.87 | -156.94% |
| MTD | Mettler-Toledo International Inc | 26.96 | -157.13% |
| DHR | Danaher Corp | 33.26 | -170.47% |
| ILMN | Illumina Inc | 34.97 | -174.10% |
| ICLR | Icon Plc | 39.55 | -183.79% |
| IDXX | Idexx Laboratories Inc | 40.14 | -185.04% |
| VCYT | Veracyte Inc | 40.15 | -185.08% |
| RVTY | Revvity Inc | 45.79 | -197.03% |
| SHC | Sotera Health Company | 63.43 | -234.40% |
| WAT | Waters Corp | 93.81 | -298.77% |